Other OTC - Other OTC Delayed Price. Currency in USD
-0.0139 (-4.14%)
At close: 3:15PM EST
Stock chart is not supported by your current browser
Previous Close0.3355
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.3000 - 0.3400
52 Week Range0.2100 - 0.8600
Avg. Volume95,541
Market Cap9.295M
Beta (3Y Monthly)1.95
PE Ratio (TTM)N/A
EPS (TTM)-0.6810
Earnings DateMay 17, 2019 - May 20, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.75
  • Business Wire

    EVIO Labs Expands Oregon Testing Capability

    EVIO Inc. (the “Company” or “EVIO”) (EVIO) is pleased to announce that EVIO Labs Portland and EVIO Labs Medford recently expanded their lab capabilities and services to further meet the needs of the State of Oregon’s evolving, yet expanding, Cannabis and Hemp markets. EVIO Labs Portland has been granted accreditation to perform pesticide testing, and now joins EVIO Labs Medford, which received its accreditation to perform residual solvents testing earlier in the fall, as a fully accredited lab.

  • MoneyShow

    EVIO, Inc. EVIO- 2019 Top Picks' Mid-Year Update

    Jason Williams, contributing editor to The Wealth Advisory, picked EVIO, Inc. (EVIO) as his top high-risk speculation for 2019. The stock has since risen 19%. Here's his update on the cannabis-related stock.

  • Business Wire

    EVIO, Inc. Engages in Strategic Partnership to launch EVIO Labs Costa Mesa

    EVIO Inc. (“EVIO” or the “Company”), (EVIO), a leading provider of testing and research for the regulated cannabis and hemp industry in North America announced today that it has engaged in a strategic partnership with Gexin Analytical Labs (“Gexin”) to complete the buildout and operation of EVIO Labs Costa Mesa. This partnership paves the way for EVIO Labs to realize its vision of providing analytical testing services throughout California. EVIO Labs Costa Mesa will be the only analytical testing lab in Costa Mesa’s coveted “Green Zone,” positively positioned adjacent to the fourteen licensed distributors that operate within 1,000 feet of the lab’s location, as well as hundreds of distributors throughout Orange and Los Angeles counties.

  • GlobeNewswire

    EVIO Inc. Closes First Tranche Equity Financing

    HENDERSON, Nev., April 10, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- EVIO, Inc. (EVIO), (the "Company") a leading North American provider of hemp and cannabis testing for the regulated cannabis industry, is pleased to announce that it has closed an initial tranche in its offering ("Offering") of Units in the Company, for an aggregate amount of $586,000. Each Unit consists of one share of EVIO common stock ("Stock") at a price of $0.40, and a share purchase warrant (each, a "Warrant") in the amount of one full Warrant per Unit. Each whole Warrant shall entitle the holder thereof to purchase one additional common share of the Offeror (each a "Warrant Share") at an exercise price of US $0.65 per Warrant Share for a period of 24 months after the closing of the Offering.

  • MoneyShow

    Top Picks 2019- EVIO EVIO

    I'm extremely bullish on cannabis, in case you couldn't tell. This is the birth of an industry that is set to grow to epic proportions. We're talking tens, maybe even hundreds, of billions of dollars a year, asserts Jason Williams, editor of The Wealth Advisory.

  • Business Wire

    EVIO Canada’s Keystone Labs Ready for Federal Regulatory Cannabis Pesticide Contamination Testing

    Test results must be provided to LPs before the products can be sold